PPP1R17 and obesity due to melanocortin 4 receptor deficiency: In addition to its basic science importance, these findings could have therapeutic applications, as they suggest that pharmacologic activation of PPP1R17 neurons could potentially reduce weight in settings of obesity and binge-like eating.